×

Subscribe Today

Get our free articles delivered directly to your email!

Continue reading

Corvus Pharmaceuticals Inc. (CRVS) NASDAQ

$1.40 - (-)

Market Cap: $68.55M

As of 10/04/23 04:00 PM EDT. Market closed.

(CRVS)

Corvus Pharmaceuticals Inc. (CRVS)
NASDAQ

$1.40
- (-)

Market Cap: $68.55M

As of 10/04/23 04:00 PM EDT. Market closed.

corvus pharmaceuticals is a clinical-stage biopharmaceutical company focused on the development of novel, first-in-class agents that target the immune system to treat patients with cancer. with accomplished and talented scientists, and top-tier investors, we are well positioned in an exciting new era of ... read more

corvus pharmaceuticals is a clinical-stage biopharmaceutical company focused on the development of novel, first-in-class agents that target the immune system to treat patients with cancer. with accomplished and talented scientists, and top-tier investors, we are well positioned in an exciting new era of immuno-oncology. read less

COMPANY PROFILE
Sector
Manufacturing
Industry
Pharmaceutical Preparation Manufacturing
CEO
Richard Miller
Full Time Employees
36
CEO Compensation (Base)
$302,961
CEO Compensation (Total)
$1.36M
URL
Address
863 Mitten Rd Ste 102, California, Burlingame, 94010-1311.
Sector
Manufacturing
Industry
Pharmaceutical Preparation Manufacturing
CEO
Richard Miller
Full Time Employees
36
CEO Compensation (Base)
$302,961
CEO Compensation (Total)
$1.36M
Address
863 Mitten Rd Ste 102, California, Burlingame, 94010-1311.
PRICE CHART FOR CORVUS PHARMACEUTICALS INC
1w
1m
3m
6m
YTD
1y
5y
MAX
From: To:
NEWS
INSIDEARBITRAGE ARTICLES
KEY STATS
Open
$1.43
Previous Close
$1.40
Days Range
$1.38 - $1.44
52 week range
$0.61 - $4.19
Volume
46,846
Avg. Volume (30 days)
351,853
Market Cap
$68.55M
Dividend Yield
-
P/E
-
Shares Outstanding
48,965,862
Open
$1.43
Previous Close
$1.40
Days Range
$1.38 - $1.44
52 week range
$0.61 - $4.19
Volume
46,846
Avg. Volume (30 days)
351,853
Market Cap
$68.55M
Dividend Yield
-
P/E
-
Shares Outstanding
48,965,862
FINANCIAL STATEMENTS FOR CORVUS PHARMACEUTICALS INC
LOADING...

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

INSIDER TRANSACTIONS FOR CORVUS PHARMACEUTICALS INC
OwnerRelationshipDateTransactionCost# SharesValue($)Total SharesForm 4
Grais LindaDirectorMay 15, 2023 Buy$2.4510,00024,50010,000May 16, 2023, 04:54 PM
Jones William BentonSee RemarksDec 20, 2022 Buy$0.7920,00015,800133,773Dec 20, 2022, 06:22 PM
LEA LEIVChief Financial OfficerDec 14, 2022 Buy$0.844,0003,364133,238Dec 15, 2022, 04:33 PM
LEA LEIVChief Financial OfficerDec 13, 2022 Buy$0.7430,00022,275129,238Dec 15, 2022, 04:33 PM
MILLER RICHARD A MDPresident and CEODec 14, 2022 Buy$0.7810,0007,8121,490,119Dec 15, 2022, 04:32 PM
MILLER RICHARD A MDPresident and CEODec 13, 2022 Buy$0.7450,00037,0151,480,119Dec 15, 2022, 04:32 PM
MILLER RICHARD A MDPresident and CEOSep 28, 2022 Buy$0.7625,00019,0701,394,405Sep 28, 2022, 05:45 PM
MILLER RICHARD A MDPresident and CEOSep 20, 2022 Buy$0.8120,00016,2531,369,405Sep 20, 2022, 06:58 PM
MILLER RICHARD A MDPresident and CEOJun 27, 2022 Buy$1.005,0004,9851,349,405Jun 28, 2022, 07:15 PM
MILLER RICHARD A MDPresident and CEOJun 24, 2022 Buy$1.035,0005,1501,344,405Jun 28, 2022, 07:15 PM
MILLER RICHARD A MDPresident and CEOJun 06, 2022 Buy$1.018908991,339,405Jun 06, 2022, 06:43 PM
MILLER RICHARD A MDPresident and CEOJun 02, 2022 Buy$0.985,0004,8981,338,515Jun 06, 2022, 06:43 PM
MILLER RICHARD A MDPresident and CEOMar 31, 2022 Buy$1.6415,00024,5341,333,515Apr 01, 2022, 04:18 PM
LEA LEIVChief Financial OfficerMar 17, 2022 Buy$1.6513,87822,89999,238Mar 17, 2022, 07:10 PM
LEA LEIVChief Financial OfficerMar 16, 2022 Buy$1.5435,16054,14685,360Mar 17, 2022, 07:10 PM
MILLER RICHARD A MDPresident and CEOMar 17, 2022 Buy$1.595,0007,9501,318,515Mar 17, 2022, 07:09 PM
MILLER RICHARD A MDPresident and CEOMar 15, 2022 Buy$1.4725,00036,6501,313,515Mar 17, 2022, 07:09 PM
EcoR1 Capital, LLC10% OwnerOct 01, 2021 Sale$4.962,000,0009,928,80081,077Oct 01, 2021, 07:39 PM
EcoR1 Capital, LLC10% OwnerSep 30, 2021 Sale$5.043,000,00015,131,1012,081,077Oct 01, 2021, 07:39 PM
ORBIMED ADVISORS LLCDirectorSep 20, 2021 Sale$6.091,109,6446,757,7326,943,654Sep 22, 2021, 05:27 PM
Thompson Peter A.DirectorSep 20, 2021 Sale$6.091,109,6446,757,7326,943,654Sep 22, 2021, 05:24 PM
MILLER RICHARD A MDPresident and CEOAug 20, 2021 Buy$1.9310,00019,2541,288,515Aug 23, 2021, 09:01 PM
ORBIMED ADVISORS LLCDirectorFeb 17, 2021 Buy$3.501,285,7144,499,9998,053,298Feb 19, 2021, 04:52 PM
Thompson Peter A.DirectorFeb 17, 2021 Buy$3.501,285,7144,499,9998,053,298Feb 19, 2021, 04:47 PM
MILLER RICHARD A MDPresident and CEOFeb 17, 2021 Buy$3.50100,000350,0001,278,515Feb 17, 2021, 04:44 PM
Novo Holdings A/S10% OwnerJul 07, 2020 Sale$5.25796,6224,183,3812,130,938Jul 09, 2020, 04:35 PM
Novo Holdings A/S10% OwnerJul 08, 2020 Sale$5.37741,4403,985,1661,389,498Jul 09, 2020, 04:35 PM
MILLER RICHARD A MDPresident and CEONov 13, 2019 Buy$3.0014,73644,2401,178,515Nov 14, 2019, 04:14 PM
MILLER RICHARD A MDPresident and CEONov 12, 2019 Buy$2.902727891,163,779Nov 14, 2019, 04:14 PM
Thompson Peter A.DirectorAug 06, 2019 Buy$3.51142,656500,7236,767,584Aug 08, 2019, 05:00 PM
ORBIMED ADVISORS LLCDirectorAug 06, 2019 Buy$3.51142,656500,7236,767,584Aug 08, 2019, 04:59 PM
MILLER RICHARD A MDPresident and CEOAug 06, 2019 Buy$3.585,00017,8751,161,007Aug 08, 2019, 04:07 PM
MILLER RICHARD A MDPresident and CEOAug 07, 2019 Buy$3.542,5008,8501,163,507Aug 08, 2019, 04:07 PM
Novo Holdings A/S10% OwnerJul 25, 2019 Sale$4.001,400,0005,600,0002,927,560Jul 25, 2019, 07:21 PM
Novo Holdings A/S10% OwnerJul 24, 2019 Sale$5.0153,240266,7114,327,560Jul 25, 2019, 07:21 PM
Novo Holdings A/S10% OwnerJul 23, 2019 Sale$5.3239,716211,1344,380,800Jul 25, 2019, 07:21 PM
Thompson Peter A.DirectorJul 01, 2019 Buy$3.9159,243231,6406,624,928Jul 01, 2019, 06:16 PM
Thompson Peter A.DirectorJun 28, 2019 Buy$3.72565,1782,102,4626,565,685Jul 01, 2019, 06:16 PM
Thompson Peter A.DirectorJun 27, 2019 Buy$3.3432,923109,9636,000,507Jul 01, 2019, 06:16 PM
ORBIMED ADVISORS LLCDirectorJul 01, 2019 Buy$3.9159,243231,6406,624,928Jul 01, 2019, 06:15 PM
ORBIMED ADVISORS LLCDirectorJun 28, 2019 Buy$3.72565,1782,102,4626,565,685Jul 01, 2019, 06:15 PM
ORBIMED ADVISORS LLCDirectorJun 27, 2019 Buy$3.3432,923109,9636,000,507Jul 01, 2019, 06:15 PM
MILLER RICHARD A MDPresident and CEOJun 14, 2019 Buy$3.4011,65739,6661,156,007Jun 17, 2019, 04:08 PM
MILLER RICHARD A MDPresident and CEOJun 13, 2019 Buy$3.523431,2071,144,350Jun 17, 2019, 04:08 PM
MILLER RICHARD A MDPresident and CEOJun 11, 2019 Buy$3.676,00022,0201,144,007Jun 11, 2019, 04:55 PM
MILLER RICHARD A MDPresident and CEOJun 07, 2019 Buy$3.379,21231,0191,138,007Jun 11, 2019, 04:55 PM
LEA LEIVChief Financial OfficerJun 07, 2019 Buy$3.3810,00033,80050,200Jun 10, 2019, 04:12 PM
LEA LEIVChief Financial OfficerJun 06, 2019 Buy$3.5615,50055,18040,200Jun 10, 2019, 04:12 PM
MILLER RICHARD A MDPresident and CEODec 27, 2018 Buy$3.2920,00065,8841,128,795Dec 31, 2018, 04:16 PM
LEA LEIVChief Financial OfficerDec 21, 2018 Buy$4.1524,700102,40924,700Dec 27, 2018, 04:08 PM
MILLER RICHARD A MDPresident and CEODec 20, 2018 Buy$4.3910,00043,9501,108,795Dec 26, 2018, 04:05 PM
MILLER RICHARD A MDPresident and CEODec 06, 2018 Buy$5.995,00029,9341,118,795Dec 10, 2018, 04:05 PM
MILLER RICHARD A MDPresident and CEODec 04, 2018 Buy$5.951,5028,9371,113,795Dec 06, 2018, 04:06 PM
Thompson Peter A.DirectorMar 12, 2018 Buy$8.50588,2354,999,9985,967,584Mar 14, 2018, 02:05 PM
ORBIMED ADVISORS LLCDirectorMar 12, 2018 Buy$8.50588,2354,999,9985,967,584Mar 14, 2018, 01:58 PM
Novo Holdings A/S10% OwnerMar 12, 2018 Buy$8.501,176,4709,999,9954,420,516Mar 13, 2018, 05:12 PM
Gould Terry PDirectorMar 12, 2018 Buy$8.50588,2354,999,998236,128Mar 13, 2018, 04:07 PM
ADAMS STREET PARTNERS LLC10% OwnerMar 12, 2018 Buy$8.50588,2354,999,998236,128Mar 13, 2018, 03:30 PM
MILLER RICHARD A MDPresident and CEOMar 12, 2018 Buy$8.50100,000850,0001,112,293Mar 12, 2018, 04:05 PM
MILLER RICHARD A MDPresident and CEONov 20, 2017 Buy$10.7810,000107,8501,012,293Nov 22, 2017, 04:06 PM
Novo Holdings A/S10% OwnerJun 23, 2017 Buy$10.9520,000219,0003,244,046Jun 27, 2017, 04:52 PM
MILLER RICHARD A MDPresident and CEOJun 13, 2017 Buy$9.955,00049,7251,002,293Jun 13, 2017, 04:06 PM
MILLER RICHARD A MDPresident and CEOJun 12, 2017 Buy$9.8211,216110,185997,293Jun 13, 2017, 04:06 PM
MILLER RICHARD A MDPresident and CEOJun 09, 2017 Buy$9.928,78487,174986,077Jun 13, 2017, 04:06 PM
Thompson Peter A.DirectorJun 24, 2016 Buy$12.9990011,6915,379,349Jun 27, 2016, 06:51 PM
Thompson Peter A.DirectorJun 23, 2016 Buy$12.921001,2925,378,449Jun 27, 2016, 06:51 PM
ORBIMED ADVISORS LLCDirectorJun 24, 2016 Buy$12.9990011,6915,379,349Jun 27, 2016, 06:47 PM
ORBIMED ADVISORS LLCDirectorJun 23, 2016 Buy$12.921001,2925,378,449Jun 27, 2016, 06:47 PM
Thompson Peter A.DirectorJun 21, 2016 Buy$12.8726,083335,6885,378,349Jun 21, 2016, 07:00 PM
Thompson Peter A.DirectorJun 17, 2016 Buy$12.4812,300153,5045,352,266Jun 21, 2016, 07:00 PM
ORBIMED ADVISORS LLCDirectorJun 21, 2016 Buy$12.8726,083335,6885,378,349Jun 21, 2016, 06:55 PM
ORBIMED ADVISORS LLCDirectorJun 17, 2016 Buy$12.4812,300153,5045,352,266Jun 21, 2016, 06:55 PM
Thompson Peter A.DirectorJun 16, 2016 Buy$12.045,00060,2005,339,966Jun 16, 2016, 06:05 PM
Thompson Peter A.DirectorJun 15, 2016 Buy$11.945,00059,7005,334,966Jun 16, 2016, 06:05 PM
Thompson Peter A.DirectorJun 14, 2016 Buy$12.7110,000127,1005,329,966Jun 16, 2016, 06:05 PM
ORBIMED ADVISORS LLCDirectorJun 14, 2016 Buy$12.7110,000127,1005,329,966Jun 16, 2016, 05:59 PM
ORBIMED ADVISORS LLCDirectorJun 16, 2016 Buy$12.045,00060,2005,339,966Jun 16, 2016, 05:59 PM
ORBIMED ADVISORS LLCDirectorJun 15, 2016 Buy$11.945,00059,7005,334,966Jun 16, 2016, 05:59 PM
Thompson Peter A.DirectorJun 10, 2016 Buy$12.9820,000259,6005,319,966Jun 13, 2016, 05:23 PM
Thompson Peter A.DirectorJun 09, 2016 Buy$12.9530,000388,5005,299,966Jun 13, 2016, 05:23 PM
ORBIMED ADVISORS LLCDirectorJun 10, 2016 Buy$12.9820,000259,6005,319,966Jun 13, 2016, 05:18 PM
ORBIMED ADVISORS LLCDirectorJun 09, 2016 Buy$12.9530,000388,5005,299,966Jun 13, 2016, 05:18 PM
Thompson Peter A.DirectorMay 20, 2016 Buy$13.094,71661,7325,269,966May 24, 2016, 04:48 PM
ORBIMED ADVISORS LLCDirectorMay 20, 2016 Buy$13.094,71661,7325,269,966May 24, 2016, 04:37 PM
ORBIMED ADVISORS LLCDirectorMay 19, 2016 Buy$12.132,60031,5255,265,250May 20, 2016, 05:21 PM
ORBIMED ADVISORS LLCDirectorMay 18, 2016 Buy$11.554,20048,5105,262,650May 20, 2016, 05:21 PM
Thompson Peter A.DirectorMay 18, 2016 Buy$11.554,20048,5105,262,650May 20, 2016, 04:27 PM
Thompson Peter A.DirectorMay 19, 2016 Buy$12.132,60031,5255,265,250May 20, 2016, 04:27 PM
MILLER RICHARD A MDPresident and CEOMay 13, 2016 Buy$9.943002,9811,077,293May 16, 2016, 06:38 PM
MILLER RICHARD A MDPresident and CEOMay 12, 2016 Buy$10.0030,000300,0001,076,993May 16, 2016, 06:38 PM
Novo A/S10% OwnerMay 12, 2016 Buy$10.0070,000700,0003,224,046May 16, 2016, 05:01 PM
Novo A/S10% OwnerMar 29, 2016 Buy$15.00666,6669,999,9903,154,046Mar 30, 2016, 01:07 PM
ORBIMED ADVISORS LLCDirectorMar 29, 2016 Buy$15.00550,0008,250,0005,258,450Mar 29, 2016, 12:21 PM
Thompson Peter A.DirectorMar 29, 2016 Buy$15.00550,0008,250,0005,258,450Mar 29, 2016, 12:00 PM
ADAMS STREET PARTNERS LLC10% OwnerMar 29, 2016 Buy$15.00200,0003,000,000736,033Mar 29, 2016, 11:54 AM
Gould Terry PDirectorMar 29, 2016 Buy$15.00200,0003,000,000736,033Mar 29, 2016, 11:39 AM
Load More Insider Transactions
Buy Sale Option Exercise
OwnerRelationshipDateValue($)
Grais LindaDirector05/15/202324,500
Jones William BentonSee Remarks12/20/202215,800
LEA LEIVChief Financial Officer12/14/20223,364
LEA LEIVChief Financial Officer12/13/202222,275
MILLER RICHARD A MDPresident and CEO12/14/20227,812
MILLER RICHARD A MDPresident and CEO12/13/202237,015
MILLER RICHARD A MDPresident and CEO09/28/202219,070
MILLER RICHARD A MDPresident and CEO09/20/202216,253
MILLER RICHARD A MDPresident and CEO06/27/20224,985
MILLER RICHARD A MDPresident and CEO06/24/20225,150
MILLER RICHARD A MDPresident and CEO06/06/2022899
MILLER RICHARD A MDPresident and CEO06/02/20224,898
MILLER RICHARD A MDPresident and CEO03/31/202224,534
LEA LEIVChief Financial Officer03/17/202222,899
LEA LEIVChief Financial Officer03/16/202254,146
MILLER RICHARD A MDPresident and CEO03/17/20227,950
MILLER RICHARD A MDPresident and CEO03/15/202236,650
EcoR1 Capital, LLC10% Owner10/01/20219,928,800
EcoR1 Capital, LLC10% Owner09/30/202115,131,101
ORBIMED ADVISORS LLCDirector09/20/20216,757,732
Thompson Peter A.Director09/20/20216,757,732
MILLER RICHARD A MDPresident and CEO08/20/202119,254
ORBIMED ADVISORS LLCDirector02/17/20214,499,999
Thompson Peter A.Director02/17/20214,499,999
MILLER RICHARD A MDPresident and CEO02/17/2021350,000
Novo Holdings A/S10% Owner07/07/20204,183,381
Novo Holdings A/S10% Owner07/08/20203,985,166
MILLER RICHARD A MDPresident and CEO11/13/201944,240
MILLER RICHARD A MDPresident and CEO11/12/2019789
Thompson Peter A.Director08/06/2019500,723
ORBIMED ADVISORS LLCDirector08/06/2019500,723
MILLER RICHARD A MDPresident and CEO08/06/201917,875
MILLER RICHARD A MDPresident and CEO08/07/20198,850
Novo Holdings A/S10% Owner07/25/20195,600,000
Novo Holdings A/S10% Owner07/24/2019266,711
Novo Holdings A/S10% Owner07/23/2019211,134
Thompson Peter A.Director07/01/2019231,640
Thompson Peter A.Director06/28/20192,102,462
Thompson Peter A.Director06/27/2019109,963
ORBIMED ADVISORS LLCDirector07/01/2019231,640
ORBIMED ADVISORS LLCDirector06/28/20192,102,462
ORBIMED ADVISORS LLCDirector06/27/2019109,963
MILLER RICHARD A MDPresident and CEO06/14/201939,666
MILLER RICHARD A MDPresident and CEO06/13/20191,207
MILLER RICHARD A MDPresident and CEO06/11/201922,020
MILLER RICHARD A MDPresident and CEO06/07/201931,019
LEA LEIVChief Financial Officer06/07/201933,800
LEA LEIVChief Financial Officer06/06/201955,180
MILLER RICHARD A MDPresident and CEO12/27/201865,884
LEA LEIVChief Financial Officer12/21/2018102,409
MILLER RICHARD A MDPresident and CEO12/20/201843,950
MILLER RICHARD A MDPresident and CEO12/06/201829,934
MILLER RICHARD A MDPresident and CEO12/04/20188,937
Thompson Peter A.Director03/12/20184,999,998
ORBIMED ADVISORS LLCDirector03/12/20184,999,998
Novo Holdings A/S10% Owner03/12/20189,999,995
Gould Terry PDirector03/12/20184,999,998
ADAMS STREET PARTNERS LLC10% Owner03/12/20184,999,998
MILLER RICHARD A MDPresident and CEO03/12/2018850,000
MILLER RICHARD A MDPresident and CEO11/20/2017107,850
Novo Holdings A/S10% Owner06/23/2017219,000
MILLER RICHARD A MDPresident and CEO06/13/201749,725
MILLER RICHARD A MDPresident and CEO06/12/2017110,185
MILLER RICHARD A MDPresident and CEO06/09/201787,174
Thompson Peter A.Director06/24/201611,691
Thompson Peter A.Director06/23/20161,292
ORBIMED ADVISORS LLCDirector06/24/201611,691
ORBIMED ADVISORS LLCDirector06/23/20161,292
Thompson Peter A.Director06/21/2016335,688
Thompson Peter A.Director06/17/2016153,504
ORBIMED ADVISORS LLCDirector06/21/2016335,688
ORBIMED ADVISORS LLCDirector06/17/2016153,504
Thompson Peter A.Director06/16/201660,200
Thompson Peter A.Director06/15/201659,700
Thompson Peter A.Director06/14/2016127,100
ORBIMED ADVISORS LLCDirector06/14/2016127,100
ORBIMED ADVISORS LLCDirector06/16/201660,200
ORBIMED ADVISORS LLCDirector06/15/201659,700
Thompson Peter A.Director06/10/2016259,600
Thompson Peter A.Director06/09/2016388,500
ORBIMED ADVISORS LLCDirector06/10/2016259,600
ORBIMED ADVISORS LLCDirector06/09/2016388,500
Thompson Peter A.Director05/20/201661,732
ORBIMED ADVISORS LLCDirector05/20/201661,732
ORBIMED ADVISORS LLCDirector05/19/201631,525
ORBIMED ADVISORS LLCDirector05/18/201648,510
Thompson Peter A.Director05/18/201648,510
Thompson Peter A.Director05/19/201631,525
MILLER RICHARD A MDPresident and CEO05/13/20162,981
MILLER RICHARD A MDPresident and CEO05/12/2016300,000
Novo A/S10% Owner05/12/2016700,000
Novo A/S10% Owner03/29/20169,999,990
ORBIMED ADVISORS LLCDirector03/29/20168,250,000
Thompson Peter A.Director03/29/20168,250,000
ADAMS STREET PARTNERS LLC10% Owner03/29/20163,000,000
Gould Terry PDirector03/29/20163,000,000
Load More Insider Transactions
FUNDS WITH A POSITION IN CORVUS PHARMACEUTICALS INC
Fund# Shares Owned% of Portfolio% ChangeInvesting Style
ORBIMED ADVISORS LLC6,943,6540.29%No changeOther
BLACKROCK INC.532,3810.00003%7.94%Other
RENAISSANCE TECHNOLOGIES LLC489,6730.00162%-3.23%Other
GEODE CAPITAL MANAGEMENT, LLC342,0790.00009%14.87%Other
CHANGE IN SHARES OUTSTANDING FOR CORVUS PHARMACEUTICALS INC
STOCK BUYBACKS FOR CORVUS PHARMACEUTICALS INC
Period of Report
Previous Period
% Change in Shares
10-K/10-Q Filings
Quarter
06/30/2023
03/31/2023
2.02%
1Q
06/30/2023
12/31/2022
2.03%
2Q
06/30/2023
09/30/2022
2.03%
3Q
06/30/2023
06/30/2022
2.03%
4Q
06/30/2023
03/31/2022
2.03%
5Q
06/30/2023
12/31/2021
1.92%
6Q
06/30/2023
09/30/2021
8.08%
7Q
06/30/2023
06/30/2021
12.43%
8Q
06/30/2023
03/31/2021
37.61%
9Q
Load More

Period of Report: 06/30/2023

10-K/10-Q Filings: View

Previous Period
% Change in Shares
Quarter
03/31/2023
2.02%
1Q
12/31/2022
2.03%
2Q
09/30/2022
2.03%
3Q
06/30/2022
2.03%
4Q
03/31/2022
2.03%
5Q
12/31/2021
1.92%
6Q
09/30/2021
8.08%
7Q
06/30/2021
12.43%
8Q
03/31/2021
37.61%
9Q
Load More
BUYBACK ANNOUNCEMENT(S) FOR CORVUS PHARMACEUTICALS INC
LOADING...